A bill that would ban brand-name pharmaceutical companies from paying to stop cheaper, generic drugs from hitting the market was introduced in the...
Federal Trade Commission Chairman Jon Leibowitz said Friday that U.S. antitrust enforcers may consider revising their 17-year-old guidelines for...
By Peter Loftus Of DOW JONES NEWSWIRES U.S. antitrust authorities have decided not to challenge UCB SA's (UCB.BT) 2007 legal settlement that...
AstraZeneca (AZN) has effectively filled the supply gap following a shortage in the generic version of its blood pressure medicine Toprol XL after...
Senate Judiciary Committee members on Tuesday re-introduced a bill that would prohibit pharmaceutical companies from making payments to delay...
Belgian chemical and pharmaceutical company Solvay SA (SOLB.BT) is ready to defend itself against a lawsuit charging the company and other two...
In its latest attack on pharmaceutical settlements that delay the entry of generic drugs, the U.S. Federal Trade Commission has filed a lawsuit...
Expects to File NDA with FDA in Early to Mid-2009 WARREN, N.J., Dec. 2 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and...
In the news release, Patrick G. LePore Elected to Board of Directors of Par Pharmaceutical Companies, Inc., issued earlier today by Par...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.